Susquehanna International Group’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.4M Buy
2,817,200
+39,200
+1% +$220K ﹤0.01% 2538
2025
Q4
$19.4M Buy
2,778,000
+1,539,200
+124% +$12.1M ﹤0.01% 2245
2025
Q3
$9.58M Buy
1,238,800
+543,300
+78% +$4.24M ﹤0.01% 3098
2025
Q2
$6.06M Sell
695,500
-829,200
-54% -$6.01M ﹤0.01% 3625
2025
Q1
$12.1M Buy
1,524,700
+198,800
+15% +$2.01M ﹤0.01% 2280
2024
Q4
$12.1M Buy
1,325,900
+464,600
+54% +$4.49M ﹤0.01% 2429
2024
Q3
$7.91M Buy
861,300
+143,800
+20% +$1.19M ﹤0.01% 2937
2024
Q2
$7.02M Sell
717,500
-167,800
-19% -$2.05M ﹤0.01% 2932
2024
Q1
$13.4M Sell
885,300
-1,363,700
-61% -$24.7M ﹤0.01% 2232
2023
Q4
$48.5M Buy
2,249,000
+318,700
+17% +$5.88M 0.01% 1059
2023
Q3
$35.9M Buy
1,930,300
+753,700
+64% +$17.6M 0.01% 1245
2023
Q2
$29.8M Buy
1,176,600
+233,800
+25% +$5.88M 0.01% 1370
2023
Q1
$24.4M Sell
942,800
-807,300
-46% -$21.6M 0.01% 1506
2022
Q4
$41.4M Buy
1,750,100
+221,900
+15% +$5.98M 0.01% 993
2022
Q3
$38.7M Sell
1,528,200
-524,400
-26% -$18.4M 0.01% 957
2022
Q2
$68.2M Sell
2,052,600
-69,100
-3% -$2.94M 0.02% 679
2022
Q1
$153M Sell
2,121,700
-652,400
-24% -$47M 0.03% 489
2021
Q4
$255M Sell
2,774,100
-510,000
-16% -$61M 0.04% 387
2021
Q3
$416M Sell
3,284,100
-507,400
-13% -$73.9M 0.06% 289
2021
Q2
$630M Buy
3,791,500
+1,012,500
+36% +$164M 0.09% 180
2021
Q1
$505M Buy
2,779,000
+223,200
+9% +$51.8M 0.08% 198
2020
Q4
$511M Buy
2,555,800
+632,900
+33% +$129M 0.08% 184
2020
Q3
$422M Buy
1,922,900
+1,046,000
+119% +$222M 0.08% 179
2020
Q2
$167M Buy
876,900
+430,500
+96% +$75.4M 0.04% 343
2020
Q1
$69.2M Buy
446,400
+175,100
+65% +$20.4M 0.02% 525
2019
Q4
$22.7M Buy
271,300
+16,000
+6% +$1.22M 0.01% 1303
2019
Q3
$17.3M Buy
255,300
+2,100
+0.8% +$138K 0.01% 1453
2019
Q2
$16.8M Buy
253,200
+105,000
+71% +$6.12M 0.01% 1421
2019
Q1
$8.24M Sell
148,200
-38,800
-21% -$2.37M ﹤0.01% 1929
2018
Q4
$9.27M Sell
187,000
-32,200
-15% -$1.97M ﹤0.01% 1676
2018
Q3
$18.9M Buy
219,200
+140,900
+180% +$10M 0.01% 1365
2018
Q2
$4.54M Buy
78,300
+6,100
+8% +$298K ﹤0.01% 2829
2018
Q1
$2.91M Sell
72,200
-123,100
-63% -$4.65M ﹤0.01% 3305
2017
Q4
$6.81M Buy
195,300
+113,600
+139% +$3.77M ﹤0.01% 2190
2017
Q3
$2.71M Sell
81,700
-14,700
-15% -$482K ﹤0.01% 3385
2017
Q2
$3.35M Buy
96,400
+4,400
+5% +$128K ﹤0.01% 2984
2017
Q1
$2.3M Buy
92,000
+37,800
+70% +$786K ﹤0.01% 3457
2016
Q4
$894K Buy
54,200
+25,400
+88% +$431K ﹤0.01% 5768
2016
Q3
$527K Buy
28,800
+12,200
+73% +$214K ﹤0.01% 5968
2016
Q2
$266K Buy
+16,600
New +$194K ﹤0.01% 7155
2016
Q1
Sell
-10,400
Closed -$187K 9657
2015
Q4
$187K Buy
+10,400
New +$192K ﹤0.01% 8483

Other funds holding TDOC

Susquehanna International Group's TDOC Position: Q1 2026 in Review

Susquehanna International Group reduced its Teladoc Health (TDOC) stake by 17% in Q1 2026, selling an estimated $987K and leaving 885,526 shares worth $4.83M. The position accounts for ﹤0.01% of the portfolio, ranked #4299.

Susquehanna International Group first reported a position in TDOC in Q3 2016 and has held it in 36 quarters since. The position peaked at $241M in Q1 2021. 323 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

  • Susquehanna International Group held 885,526 shares of Teladoc Health worth $4.83M as of Q1 2026.
  • Susquehanna International Group sold 175,942 Teladoc Health shares in Q1 2026, an estimated $987K.
  • Teladoc Health made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #4299 holding.
  • Susquehanna International Group first reported a position in Teladoc Health in Q3 2016 and has held it in 36 quarters since.
  • Susquehanna International Group's Teladoc Health position peaked at $241M in Q1 2021.
  • 323 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.